RNA-seq analysis of resistant ER+ breast cancer cell lines
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP545289
下载链接
链接失效反馈官方服务：
资源简介：
This study aims to identify transcriptional differences between parental ER+ breast cancer cell lines and those that are resistant to several common endocrine therapies, including tamoxifen, fulvestrant, and aromatase inhibition. To mimic aromatase inhibitors, cells were grown in estrogen withdrawl (EWD) conditions, using phenol red free media and charcoal-stripped serum. Cells were kept in their respective treatments until RNA was procured. Overall design: Long-term treatments of T47D or UCD4 cells with 1 uM tamoxifen, 100 nM fulvestrant, or estrogen withdrawl using stripped serum and phenol red free media.
创建时间：
2025-04-17
